Skip to main content

Table 3 Adverse events of sorafenib

From: Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience

Adverse events

Grade 1–2, n

Grade 3–4, n

n, %

Diarrhea

11

0

11(57.9%)

Hand-foot syndrome

9

2

11(57.9%)

Hypertension

8

0

8(42.1%)

Alopecia

7

0

7(36.8%)

Rash

5

1

6(31.6%)

Fatigue

1

1

2(10.5%)

Nausea and vomit

1

0

1(5.3%)

Anemia

1

0

1(5.3%)

Leukocytopenia

1

0

1(5.3%)

Liver dysfunction

1

0

1(5.3%)

Elevation of uric acid

1

0

1(5.3%)